Table 2.
Regimen | Early BEV (N) | Delayed BEV (N) |
---|---|---|
BEV | 23 | 32 |
BEV/irinotecan | 58 | 77 |
BEV/temozolomide | 13 | 7 |
BEV/carboplatin | 6 | 5 |
BEV/carmustine | 1 | 1 |
BEV/lomustine | 1 | 0 |
BEV/cis-retinoic acid | 4 | 1 |
BEV/capecitabine | 1 | 1 |
BEV/erlotinib | 2 | 0 |
BEV/gemcitabine | 0 | 1 |
BEV/etoposide | 0 | 1 |
BEV/temsirolimus | 0 | 1 |
BEV/tamoxifen | 0 | 1 |
BEV/temozolomide/6-thioguanine | 0 | 1 |
BEV/carboplatin/etoposide | 1 | 0 |
BEV/irinotecan/cis-retinoic acid | 2 | 0 |
BEV/imatinib/hydroxyurea | 0 | 1 |
BEV/procarbazine/lomustine/6-Thioguanine/hydroxyurea | 0 | 3 |
Total | 112 | 133 |